Woolfson Adrian 4
4 · SANGAMO THERAPEUTICS, INC · Filed Feb 27, 2019
Insider Transaction Report
Form 4
Woolfson Adrian
EVP, Research and Development
Transactions
- Award
Stock Option (Right-to-Buy)
2019-02-25+250,000→ 250,000 totalExercise: $9.03Exp: 2029-02-24→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the February 25, 2019 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.